Prognostic scoring system and risk stratification in patients with emphysematous pyelonephritis: an 11‐year prospective study at a tertiary referral centre

Objectives To define pre‐morbid, clinical, laboratory, and imaging features and identify prognostic factors associated with morbidity and mortality in patients with emphysematous pyelonephritis (EPN) and develop a prognostic scoring system for improving management outcomes. Patients and Methods From...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BJU international 2021-04, Vol.127 (4), p.418-427
Hauptverfasser: Krishnamoorthy, Sriram, Zumla, Alimuddin, Sekar, Hariharasudhan, Muneer, Asif, Thiruvengadam, Gayathri, Kumaresan, Natarajan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 427
container_issue 4
container_start_page 418
container_title BJU international
container_volume 127
creator Krishnamoorthy, Sriram
Zumla, Alimuddin
Sekar, Hariharasudhan
Muneer, Asif
Thiruvengadam, Gayathri
Kumaresan, Natarajan
description Objectives To define pre‐morbid, clinical, laboratory, and imaging features and identify prognostic factors associated with morbidity and mortality in patients with emphysematous pyelonephritis (EPN) and develop a prognostic scoring system for improving management outcomes. Patients and Methods From January 2009 to December 2019, we performed a prospective study of all patients with a suspected diagnosis of EPN referred to a specialist tertiary centre in South India. All patients who underwent non‐contrast computed tomography of the abdomen and those diagnosed with EPN were included in this study. Demographic parameters, imaging, haematological and microbiology results were recorded. Patients were divided into three groups: Group 1, patients who survived without any intervention; Group 2, those who survived with surgical intervention; and Group 3, those who died with or without intervention. A prognostic scoring system was developed from 18 different parameters and risk stratification was developed. The scores were correlated with overall prognosis. Results Data from 131 patients with EPN enrolled in the study were analysed: Group 1 (n = 22), Group 2 (n = 102) and Group 3 (n = 7). By using univariate analysis, 10 factors were identified to be significantly associated with prognosis. Diabetes mellitus was the most common comorbidity. Shock at initial admission indicated a poor prognosis and warranted immediate attention (P 
doi_str_mv 10.1111/bju.15225
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2439631586</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2511089704</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3885-41c23e1b5380344b8e80e2c43b24b0ca964b01733d2baa07b5090f2096b1db353</originalsourceid><addsrcrecordid>eNp1kU1uFDEQhS0EImFgkQtEltjAYhL_9nRnB1H4UyRYEImdZbtrMp50uxvbnah3OUIuwOU4CQWTsEDCC1ep9OmpXj1CDjg74viO3XY64loI_Yjsc1WppeLs2-OHnjXVHnmW85YxHFT6KdmTol5xpuQ--fElDZdxyCV4mv2QQrykec4FempjS1PIVzSXZEtYB4__EGmIdMQOYsn0JpQNhX7czBl6W4Yp03GGbogwblIoIZ-gDOX85-3dDDbRMQ15BF_CNaDs1M7UFmppgVSCTTNNsIaUbEc9yid4Tp6sbZfhxX1dkIt3Z19PPyzPP7__ePrmfOllXWu064UE7rSsmVTK1VAzEF5JJ5Rj3jYVFr6SshXOWrZymjVsLfAwjrdOarkgr3a6uN_3CXIxfcgeus5GQE9GKNlUkuu6QvTlP-h2mFLE7YzQnLO6WeFhF-T1jvJoOKMrM6bQo0PDmfmdmcHMzJ_MkD28V5xcD-1f8iEkBI53wE3oYP6_knn76WIn-QsxxaQu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2511089704</pqid></control><display><type>article</type><title>Prognostic scoring system and risk stratification in patients with emphysematous pyelonephritis: an 11‐year prospective study at a tertiary referral centre</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Krishnamoorthy, Sriram ; Zumla, Alimuddin ; Sekar, Hariharasudhan ; Muneer, Asif ; Thiruvengadam, Gayathri ; Kumaresan, Natarajan</creator><creatorcontrib>Krishnamoorthy, Sriram ; Zumla, Alimuddin ; Sekar, Hariharasudhan ; Muneer, Asif ; Thiruvengadam, Gayathri ; Kumaresan, Natarajan</creatorcontrib><description>Objectives To define pre‐morbid, clinical, laboratory, and imaging features and identify prognostic factors associated with morbidity and mortality in patients with emphysematous pyelonephritis (EPN) and develop a prognostic scoring system for improving management outcomes. Patients and Methods From January 2009 to December 2019, we performed a prospective study of all patients with a suspected diagnosis of EPN referred to a specialist tertiary centre in South India. All patients who underwent non‐contrast computed tomography of the abdomen and those diagnosed with EPN were included in this study. Demographic parameters, imaging, haematological and microbiology results were recorded. Patients were divided into three groups: Group 1, patients who survived without any intervention; Group 2, those who survived with surgical intervention; and Group 3, those who died with or without intervention. A prognostic scoring system was developed from 18 different parameters and risk stratification was developed. The scores were correlated with overall prognosis. Results Data from 131 patients with EPN enrolled in the study were analysed: Group 1 (n = 22), Group 2 (n = 102) and Group 3 (n = 7). By using univariate analysis, 10 factors were identified to be significantly associated with prognosis. Diabetes mellitus was the most common comorbidity. Shock at initial admission indicated a poor prognosis and warranted immediate attention (P &lt; 0.001). Conclusions A multi‐disciplinary approach, a high index of clinical suspicion, an early diagnosis and administration of culture‐specific antibiotics with identification of prognostic indicators and risk stratification, allows prompt and appropriate medical and surgical treatments that could improve EPN management outcomes.</description><identifier>ISSN: 1464-4096</identifier><identifier>EISSN: 1464-410X</identifier><identifier>DOI: 10.1111/bju.15225</identifier><identifier>PMID: 32871043</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Antibiotics ; Computed tomography ; Diabetes mellitus ; Diagnosis ; emphysematous pyelonephritis ; haemodialysis ; Hemodialysis ; Medical prognosis ; Morbidity ; nephrectomy ; Patients ; percutaneous nephrostomy ; Prognosis ; Pyelonephritis ; UroUTI</subject><ispartof>BJU international, 2021-04, Vol.127 (4), p.418-427</ispartof><rights>2020 The Authors BJU International © 2020 BJU International Published by John Wiley &amp; Sons Ltd</rights><rights>2020 The Authors BJU International © 2020 BJU International Published by John Wiley &amp; Sons Ltd.</rights><rights>BJUI © 2021 BJU International</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3885-41c23e1b5380344b8e80e2c43b24b0ca964b01733d2baa07b5090f2096b1db353</citedby><cites>FETCH-LOGICAL-c3885-41c23e1b5380344b8e80e2c43b24b0ca964b01733d2baa07b5090f2096b1db353</cites><orcidid>0000-0002-0045-9415</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbju.15225$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbju.15225$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32871043$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Krishnamoorthy, Sriram</creatorcontrib><creatorcontrib>Zumla, Alimuddin</creatorcontrib><creatorcontrib>Sekar, Hariharasudhan</creatorcontrib><creatorcontrib>Muneer, Asif</creatorcontrib><creatorcontrib>Thiruvengadam, Gayathri</creatorcontrib><creatorcontrib>Kumaresan, Natarajan</creatorcontrib><title>Prognostic scoring system and risk stratification in patients with emphysematous pyelonephritis: an 11‐year prospective study at a tertiary referral centre</title><title>BJU international</title><addtitle>BJU Int</addtitle><description>Objectives To define pre‐morbid, clinical, laboratory, and imaging features and identify prognostic factors associated with morbidity and mortality in patients with emphysematous pyelonephritis (EPN) and develop a prognostic scoring system for improving management outcomes. Patients and Methods From January 2009 to December 2019, we performed a prospective study of all patients with a suspected diagnosis of EPN referred to a specialist tertiary centre in South India. All patients who underwent non‐contrast computed tomography of the abdomen and those diagnosed with EPN were included in this study. Demographic parameters, imaging, haematological and microbiology results were recorded. Patients were divided into three groups: Group 1, patients who survived without any intervention; Group 2, those who survived with surgical intervention; and Group 3, those who died with or without intervention. A prognostic scoring system was developed from 18 different parameters and risk stratification was developed. The scores were correlated with overall prognosis. Results Data from 131 patients with EPN enrolled in the study were analysed: Group 1 (n = 22), Group 2 (n = 102) and Group 3 (n = 7). By using univariate analysis, 10 factors were identified to be significantly associated with prognosis. Diabetes mellitus was the most common comorbidity. Shock at initial admission indicated a poor prognosis and warranted immediate attention (P &lt; 0.001). Conclusions A multi‐disciplinary approach, a high index of clinical suspicion, an early diagnosis and administration of culture‐specific antibiotics with identification of prognostic indicators and risk stratification, allows prompt and appropriate medical and surgical treatments that could improve EPN management outcomes.</description><subject>Antibiotics</subject><subject>Computed tomography</subject><subject>Diabetes mellitus</subject><subject>Diagnosis</subject><subject>emphysematous pyelonephritis</subject><subject>haemodialysis</subject><subject>Hemodialysis</subject><subject>Medical prognosis</subject><subject>Morbidity</subject><subject>nephrectomy</subject><subject>Patients</subject><subject>percutaneous nephrostomy</subject><subject>Prognosis</subject><subject>Pyelonephritis</subject><subject>UroUTI</subject><issn>1464-4096</issn><issn>1464-410X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kU1uFDEQhS0EImFgkQtEltjAYhL_9nRnB1H4UyRYEImdZbtrMp50uxvbnah3OUIuwOU4CQWTsEDCC1ep9OmpXj1CDjg74viO3XY64loI_Yjsc1WppeLs2-OHnjXVHnmW85YxHFT6KdmTol5xpuQ--fElDZdxyCV4mv2QQrykec4FempjS1PIVzSXZEtYB4__EGmIdMQOYsn0JpQNhX7czBl6W4Yp03GGbogwblIoIZ-gDOX85-3dDDbRMQ15BF_CNaDs1M7UFmppgVSCTTNNsIaUbEc9yid4Tp6sbZfhxX1dkIt3Z19PPyzPP7__ePrmfOllXWu064UE7rSsmVTK1VAzEF5JJ5Rj3jYVFr6SshXOWrZymjVsLfAwjrdOarkgr3a6uN_3CXIxfcgeus5GQE9GKNlUkuu6QvTlP-h2mFLE7YzQnLO6WeFhF-T1jvJoOKMrM6bQo0PDmfmdmcHMzJ_MkD28V5xcD-1f8iEkBI53wE3oYP6_knn76WIn-QsxxaQu</recordid><startdate>202104</startdate><enddate>202104</enddate><creator>Krishnamoorthy, Sriram</creator><creator>Zumla, Alimuddin</creator><creator>Sekar, Hariharasudhan</creator><creator>Muneer, Asif</creator><creator>Thiruvengadam, Gayathri</creator><creator>Kumaresan, Natarajan</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0045-9415</orcidid></search><sort><creationdate>202104</creationdate><title>Prognostic scoring system and risk stratification in patients with emphysematous pyelonephritis: an 11‐year prospective study at a tertiary referral centre</title><author>Krishnamoorthy, Sriram ; Zumla, Alimuddin ; Sekar, Hariharasudhan ; Muneer, Asif ; Thiruvengadam, Gayathri ; Kumaresan, Natarajan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3885-41c23e1b5380344b8e80e2c43b24b0ca964b01733d2baa07b5090f2096b1db353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibiotics</topic><topic>Computed tomography</topic><topic>Diabetes mellitus</topic><topic>Diagnosis</topic><topic>emphysematous pyelonephritis</topic><topic>haemodialysis</topic><topic>Hemodialysis</topic><topic>Medical prognosis</topic><topic>Morbidity</topic><topic>nephrectomy</topic><topic>Patients</topic><topic>percutaneous nephrostomy</topic><topic>Prognosis</topic><topic>Pyelonephritis</topic><topic>UroUTI</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Krishnamoorthy, Sriram</creatorcontrib><creatorcontrib>Zumla, Alimuddin</creatorcontrib><creatorcontrib>Sekar, Hariharasudhan</creatorcontrib><creatorcontrib>Muneer, Asif</creatorcontrib><creatorcontrib>Thiruvengadam, Gayathri</creatorcontrib><creatorcontrib>Kumaresan, Natarajan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>BJU international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krishnamoorthy, Sriram</au><au>Zumla, Alimuddin</au><au>Sekar, Hariharasudhan</au><au>Muneer, Asif</au><au>Thiruvengadam, Gayathri</au><au>Kumaresan, Natarajan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic scoring system and risk stratification in patients with emphysematous pyelonephritis: an 11‐year prospective study at a tertiary referral centre</atitle><jtitle>BJU international</jtitle><addtitle>BJU Int</addtitle><date>2021-04</date><risdate>2021</risdate><volume>127</volume><issue>4</issue><spage>418</spage><epage>427</epage><pages>418-427</pages><issn>1464-4096</issn><eissn>1464-410X</eissn><abstract>Objectives To define pre‐morbid, clinical, laboratory, and imaging features and identify prognostic factors associated with morbidity and mortality in patients with emphysematous pyelonephritis (EPN) and develop a prognostic scoring system for improving management outcomes. Patients and Methods From January 2009 to December 2019, we performed a prospective study of all patients with a suspected diagnosis of EPN referred to a specialist tertiary centre in South India. All patients who underwent non‐contrast computed tomography of the abdomen and those diagnosed with EPN were included in this study. Demographic parameters, imaging, haematological and microbiology results were recorded. Patients were divided into three groups: Group 1, patients who survived without any intervention; Group 2, those who survived with surgical intervention; and Group 3, those who died with or without intervention. A prognostic scoring system was developed from 18 different parameters and risk stratification was developed. The scores were correlated with overall prognosis. Results Data from 131 patients with EPN enrolled in the study were analysed: Group 1 (n = 22), Group 2 (n = 102) and Group 3 (n = 7). By using univariate analysis, 10 factors were identified to be significantly associated with prognosis. Diabetes mellitus was the most common comorbidity. Shock at initial admission indicated a poor prognosis and warranted immediate attention (P &lt; 0.001). Conclusions A multi‐disciplinary approach, a high index of clinical suspicion, an early diagnosis and administration of culture‐specific antibiotics with identification of prognostic indicators and risk stratification, allows prompt and appropriate medical and surgical treatments that could improve EPN management outcomes.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>32871043</pmid><doi>10.1111/bju.15225</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-0045-9415</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1464-4096
ispartof BJU international, 2021-04, Vol.127 (4), p.418-427
issn 1464-4096
1464-410X
language eng
recordid cdi_proquest_miscellaneous_2439631586
source Wiley Online Library Journals Frontfile Complete
subjects Antibiotics
Computed tomography
Diabetes mellitus
Diagnosis
emphysematous pyelonephritis
haemodialysis
Hemodialysis
Medical prognosis
Morbidity
nephrectomy
Patients
percutaneous nephrostomy
Prognosis
Pyelonephritis
UroUTI
title Prognostic scoring system and risk stratification in patients with emphysematous pyelonephritis: an 11‐year prospective study at a tertiary referral centre
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T03%3A40%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20scoring%20system%20and%20risk%20stratification%20in%20patients%20with%20emphysematous%20pyelonephritis:%20an%2011%E2%80%90year%20prospective%20study%20at%20a%20tertiary%20referral%20centre&rft.jtitle=BJU%20international&rft.au=Krishnamoorthy,%20Sriram&rft.date=2021-04&rft.volume=127&rft.issue=4&rft.spage=418&rft.epage=427&rft.pages=418-427&rft.issn=1464-4096&rft.eissn=1464-410X&rft_id=info:doi/10.1111/bju.15225&rft_dat=%3Cproquest_cross%3E2511089704%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2511089704&rft_id=info:pmid/32871043&rfr_iscdi=true